The contrarian uncomfortable truth about CoreWeave
CoreWeave has already won, and the debate about execution risk is irrelevant.
While the market fixates on debt levels, customer concentration, and capital intensity, it’s missing the only fact that actually matters:
CoreWeave CRWV 0.00%↑ has already locked in $55.6 billion of revenue backlog under take-or-pay contracts.
The deals are done.
The cash is contractually guaranteed.
The only variable is when revenue is recognized → not if.
The hidden advantage everyone misses
Take-or-pay isn’t a flaw. It’s an insurmountable moat.
Management was explicit:
“Today, no single customer represents more than approximately 35% of our revenue backlog, down from approximately 50% last quarter and even more meaningfully from approximately 85% to begin the year. Additionally, as of Q3, more than 60% of our revenue backlog is tied to investment-grade customers.”
This isn’t concentration risk.
It’s de-risked, contracted cash flow from creditworthy counterparties.
CoreWeave has flipped the risk equation entirely: customers pay whether they use the capacity or not. If OpenAI or Meta META 0.00%↑ slow utilization, the checks still clear. CoreWeave gets paid regardless.
The market is pricing optionality that doesn’t exist
The current debate assumes competitors can “catch up” or that CoreWeave’s position is fragile.
The uncomfortable truth is the opposite: the supply chain is already locked up.
CoreWeave was:
First to deploy NVDA 0.00%↑ NVIDIA GB300 NVL72 systems
First to make NVDA 0.00%↑ NVIDIA RTX PRO 6000 Blackwell Server Edition instances generally available
They’ve secured 2.9 gigawatts of contracted power capacity, with over 1 gigawatt already contracted and expected to come online within the next 12–24 months.
The hyperscalers everyone expects to crush them? They’re capacity-constrained too.
When asked about MSFT 0.00%↑ Microsoft’s $250B OpenAI deal or ORCL 0.00%↑ Oracle’s $300B commitment, the CEO didn’t blink:
CoreWeave operates in a highly supply-constrained environment, where demand for its AI cloud platform far exceeds available capacity.
This isn’t a competitive market. It’s a rationed one.
The “debt problem” is actually validation
Critics point to $14.2B in debt as if it’s a red flag.
They miss what that debt actually represents: the world’s most sophisticated lenders underwriting contracted cash flows.
In Q3 alone, CoreWeave:
Closed DDTL 3.0 at SOFR + 4.00% (a 900 bps improvement)
Amended DDTL 2.0 to SOFR + 4.25%, materially below original terms
Raised $1.75B in senior notes at 9.0%, 25 bps cheaper than its inaugural offering
Banks don’t lower rates and extend more capital to distressed businesses.
They do it when cash flows are real, visible, and contractually protected.
The real uncomfortable truth
CoreWeave doesn’t need to “win” the future.
They’ve already sold it.
Customers have committed through 2030 and beyond, with 15–25% average prepayments baked into contracts. This isn’t speculative demand — it’s prepaid, legally binding revenue.
The CFO made this crystal clear:
“The meaningful growth in construction in progress to $6.9 billion — up $2.8 billion quarter-over-quarter — is a direct result of data center delays.”
Translation:
$6.9B of infrastructure is already paid for, already contracted, and simply waiting on powered shell delivery to flip the revenue switch.
When delays hit, customers didn’t walk. They adjusted timelines — without reducing contract value:
“The customer has agreed to adjust the delivery schedule to preserve their capacity for the full duration and total value of the original agreement.”
The simplest truth the market refuses to accept
CoreWeave is not making risky bets on future AI demand.
They’ve contractually guaranteed $55.6 billion in future revenue with take-or-pay terms, from investment-grade customers, in a supply-constrained market where few — if any — competitors can deliver at their speed or scale.
Capital intensity isn’t a weakness.
It’s the barrier that keeps competitors out.
Debt isn’t the risk.
It’s the financing mechanism for assets with guaranteed cash flows attached.
While the market debates execution risk, CoreWeave has already completed the hardest part: locking in customers, supply, power, and contracts.
Everything else is just construction timing.
The market is still asking whether CoreWeave can execute. The better question is why it’s ignoring the fact that CoreWeave already has. The revenue is contracted, the customers are locked in, and the capacity is spoken for. At this point, the debate isn’t about demand — it’s about how long it takes the market to accept that the future has already been sold.
CoreWeave has to spend $20 Billion from September 30th 2025 to March 31 2026 and they only have $14 Billion in available funds to do it. I have a detailed report below if you want to see the details.
https://mschief1994.substack.com/p/a-deep-dive-into-coreweaves-cash?r=70b06y
I believe CoreWeave has a high probability of filing for Bankruptcy in 2026. The business is in far worse shape today than the public knows. Here are 5 key issues it is facing that cumulatively will lead to its insolvency next year.
1. The Cashflow Problem
A major problem CoreWeave has is its cashflow. CoreWeave sold its future to fund its growth. Customers have already pre-paid, and the money they paid is already spent. For Example, Open AI has prepaid over $2 Billion to CoreWeave for credits that it will slowly burn through over 2 years. While CoreWeave will recognize that $2 billion as revenue they will get no cash from Open AI as Open AI will just be burning through credits. The $5.3 Billion in deferred revenue on CoreWeaves balance sheet will go down, and revenue will be recognized, but they will get no cash until those pre-paid credits are used up. This leaves no cash for CoreWeave to pay its operating expenses, or pay its amortized DDTL Loans, much less continue the $28-30 Billion in Capex they have forecasted. They are almost certainly going to have to lower the Capex and renegotiate the contracts they have with customers to survive this. While reported revenue numbers will look good the company will be in great financial stress.
2. The Credit Problem
They already have junk status with all the major rating agencies, and CDS spreads are projecting a 42% chance of default in the next 5 years (I think it is closer to 45% this year). They have $3.7 billion in current debts due 12 months from September 30th, 2025 (per the most recent 10q). Based on table 10. “Debt” in the 10q about $2.6 billion of that is amortized payments on its DDLT loans and the other is a large balloon payment of OEM Financing Arrangements from Nvidia and Dell. They have the maturities of these financing arrangements listed as due March 2026-August 2028 but given the amount of current debt they show this is extremely misleading. Almost 100% of the OEM financing debt is due in the first half of 2026. Keep in mind that as of September 30th the DDTL loans are not fully drawn, and that amortization payments on those loans start Q1 of 2026. When those loans are fully drawn current debt will rise dramatically.
Having said all of that, they do not have near enough cash to cover these payments along with operating expenses, which is why they had to have their minimum liquidity levels lowered to $100 million to avoid technical default. Furthermore, they have cross collateralized the DDTL loans with the entire company. This will likely prevent them from being able to issue more bonds or convertible bonds. This cross collateralization gives the DDTL lenders first position on chips and either first position or equal position to bondholders on the rest of the company.
This is why they need unlimited equity cures to get through the next few months. They need to be able to print stock to not default on DDLT Loans. This is all noted in the 8k reported in early January discussing the modification of CoreWeave’s DDTL loans.
3. The Equity Problem
I can send you a PDF that goes into greater detail on this, but basically the founders are converting founders shares into sellable class b shares at a clip of about 9 million shares a quarter. On top of this Magnetar, a big early investor, is selling about 27 million shares a quarter, and Magnetar along with the 3 founders already have presold shares in a VPF contract that will hit the market on June 19, 2026. In addition to this they have a 6% evergreen provision that automatically adds 6% of the total share count on Jan 1 that goes to help employees. (5% Equity and 1% Employee Stock Purchase Plans) Another 29.8 million shares. They will also need to print at least 62 million shares (assuming the stock prices stays around $78) just to survive the year. In reality they probably need much more but let’s be conservative. That means with insider selling and new shares issued, the new supply of shares will be close to 215 tradable shares. Just newly printed shares will be around 91 million. With current outstanding shares at 497 million existing shareholders will be diluted by at least 18% and the tradable share float will go up 43%. Not great for existing shareholders.
4. The Contract Execution and Construction Timing Problem
The fourth problem they have is their inability to meet deadlines and deliver on contracts. They have strict contract realization deadlines that they have to meet to secure DDTL Financing. They have to show billings by February 28, 2026, to be able to collect the remaining money on the DDTL Loans. The big one is the DDTL 3.0 loan for the Denton Open AI Facility. They cannot actually get the money from the DDTL Loan to pay suppliers until they show revenue, but they are 60-90 days behind schedule. They have cited “Weather Delay” which I believe to be totally bogus. The real reason for the delay is the redesign of the facility to meet the liquid cooling requirements of the new Blackwell chips.
Having said that, the Shell for the Denton facility was delivered to CoreWeave per The Texas Department of Licensing and Regulation permit issued on December 29th, 2025. (See the link to the permit below.) This was the final step for Core Scientific, the landlord to deliver the shell and begin collecting lease payments. It will take 5-6 months potentially to build out the facility, and to get all the chips up and going. This means that they will not be able to bill Open AI for at least 5 months. If they cannot get the facility up and running by March they will have to start paying Open AI penalty payments in the form of compute credits, if they do not have it up and running by May 1, 2026 Open AI can cancel the Denton Contract, and if it is delayed until July 1, 2026 they can terminate all deals with Coreweave. I do not believe Open AI will cancel the deal because they have already pre-paid for so much compute at such low rates. The penalties could add up to a significant number though for Coreweave further pushing out its cashflow.
The timing is a big problem for CoreWeave’s cashflow. This is where the unlimited equity cures come in. They cannot bill open AI because they are not finished installing the chips, and they cannot get the money from the DDTL loans to pay their suppliers until they bill Open AI. So, what the banks have allow them to do is substitute these “Billings” with stock sales to the open market to generate cash that will give CoreWeave liquidity to pay the banks. This is not an option. They have to do this to get their money even if they have cash in the bank to pay the loan. If they do not issue equity cures to replace billings the bank will not fund the remaining portion of the DDTL Loans. The Denton facilities billings alone are estimated to be around $100 Million /month conservatively. That means at a minimum $100 million in stock that must be issued per month of delays just to satisfy the banks and get funding. This is just for the open AI Denton, TX project. CoreWeave has 3 of these going at the same time in similar stages. Their sites at Ellendale, ND and Lancaster, PA are also experiencing similar delays.
In my opinion construction delays and contract timing risk are potentially the biggest of all the issues CoreWeave has in the short term. They could blow everything up very quickly.
5. Their Margins Suck
For this I lean on others’ research. The Kerrisdale Capital Report posted on September 15, 2025, lays everything out pretty well. Micheal Burry also has a similar view that the depreciation schedule companies are using for these chips is far to long. Basically, what they say is that reported margins are roughly 20% based on a 6 year chip life cycle, but margins are essentially 0% because the chips only actually last 4 years. Also, CoreWeave will not realize any free cashflow from its chips for 3 years due to harsh amortization schedules and high interest rates on its DDTL loans. By the time they get the DDLT loans paid off they will have made 0 money on their chips, and they will basically be worthless.
Kerrisdale Report
https://www.kerrisdalecap.com/wp-content/uploads/2025/09/Kerrisdale-CoreWeave.pdf
Employee Benefit Plan Filing
https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex103.htm
The Texas Department of Licensing and Regulation Permit
https://www.tdlr.texas.gov/TABS/Search/Project/TABS2025005706